BioXcel Therapeutics Inc
NASDAQ:BTAI

Watchlist Manager
BioXcel Therapeutics Inc Logo
BioXcel Therapeutics Inc
NASDAQ:BTAI
Watchlist
Price: 2.01 USD -2.9% Market Closed
Market Cap: 44m USD

Wall Street
Price Targets

BTAI Price Targets Summary
BioXcel Therapeutics Inc

There are no price targets for BTAI.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
BioXcel Therapeutics Inc Competitors:
Price Targets
EXAS
Exact Sciences Corp
1% Downside
397030
AprilBio Co Ltd
9% Upside
301080
Acrobiosystems Co Ltd
39% Upside
CLYM
Climb Bio Inc
213% Upside
PHM
Pharma Mar SA
32% Upside
2157
Lepu Biopharma Co Ltd
98% Upside
6855
Ascentage Pharma Group International
78% Upside
BCAX
Bicara Therapeutics Inc
80% Upside

Revenue
Forecast

Revenue Estimate
BioXcel Therapeutics Inc

The compound annual growth rate of BioXcel Therapeutics Inc's revenue for the next 4 years is 192%.

N/A
Past Growth
192%
Estimated Growth
Estimates Accuracy
-20%
Average Miss

Operating Income
Forecast

Operating Income Estimate
BioXcel Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-5%
Average Miss

Net Income
Forecast

Net Income Estimate
BioXcel Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-93%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is BTAI's stock price target?
Not Available

BTAI doesn't have any price targets made by Wall Street professionals.

What is BioXcel Therapeutics Inc's Revenue forecast?
Projected CAGR
192%

The compound annual growth rate of BioXcel Therapeutics Inc's revenue for the next 4 years is 192%.

Back to Top